Find similar content

Source channel @githubtrending · Post #14686 · May 8

#python#asr#deeplearning#generative_ai#large_language_models#machine_translation#multimodal#neural_networks#speaker_diariazation#speaker_recognition#speech_synthesis#speech_translation#tts NVIDIA NeMo is a powerful, easy-to-use platform for building, customizing, and deploying generative AI models like large language models (LLMs), vision language models, and speech AI. It lets you quickly train and fine-tune models using pre-built code and checkpoints, supports the latest model architectures, and works on cloud, data center, or edge environments. NeMo 2.0 is even more flexible and scalable, with Python-based configuration and modular design, making it simple to experiment and scale up. The main benefit is that you can create advanced AI applications faster, with less effort, and at lower cost, while getting high performance and easy deployment options[1][2][3]. https://github.com/NVIDIA/NeMo

Hashtags

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment